Saturation biopsy protocol enhances prediction of pT3 and surgical margin status on prostatectomy specimen

被引:23
作者
Descazeaud, Aurelien
Rubin, Mark
Chemama, Stephanie
Larre, Stephane
Salomon, Laurent
Allory, Yves
Vordos, Dimitri
Hoznek, Andras
Yiou, Rene
Chopin, Dominique
Abbou, Claude
de la Taille, Alexandre
机构
[1] Hop Cochin, Urol Serv, F-75014 Paris, France
[2] Hop Henri Mondor, AP HP, Dept Urol, Creteil, France
[3] Hop Henri Mondor, AP HP, Dept Pathol, Creteil, France
[4] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
prostate; biopsy; saturation; prostatic neoplasm;
D O I
10.1007/s00345-006-0134-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 21-samples saturation biopsy procedure (SBP) was developed in order to improve prostate cancer detection rate. Out of 650 patients who underwent this protocol, 150 had a clinically localized prostate cancer and underwent a radical prostatectomy. The number of cores positive for tumor was assessed in the SBP, and also in the sextant component of the SBP (SC) and in the non-sextant component of the SBP (NSC). Numbers of cores positive for tumor on SBP, SC, and NSC were significantly higher in pT3 group versus pT2 (P < 0.001 each) and in positive surgical margins (PSM) group versus no PSM (P < 0.001 each). When comparing area under the curve obtained from SBP with those obtained from NSC and SC, the SBP showed higher accuracy than the NSC and the SC for the prediction of pT3 and PSM. On multivariate analyses, SC and NSC were independent predictors of pT3 and PSM on radical prostatectomy.
引用
收藏
页码:676 / 680
页数:5
相关论文
共 18 条
[1]   ANALYSIS OF RISK-FACTORS ASSOCIATED WITH PROSTATE-CANCER EXTENSION TO THE SURGICAL MARGIN AND PELVIC NODE METASTASIS AT RADICAL PROSTATECTOMY [J].
ACKERMAN, DA ;
BARRY, JM ;
WICKLUND, RA ;
OLSON, N ;
LOWE, BA .
JOURNAL OF UROLOGY, 1993, 150 (06) :1845-1850
[2]   Pathologic features the urologist should expect on a prostate biopsy [J].
Che, MX ;
Sakr, W ;
Grignon, D .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (02) :153-161
[3]   Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy [J].
Cheng, L ;
Slezak, J ;
Bergstralh, EJ ;
Myers, RP ;
Zincke, H ;
Bostwick, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (15) :2862-2868
[4]   Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate [J].
de la Taille, A ;
Antiphon, P ;
Salomon, L ;
Cherfan, M ;
Porcher, R ;
Hoznek, A ;
Saint, F ;
Vordos, D ;
Cicco, A ;
Yiou, R ;
Zafrani, ES ;
Chopin, D ;
Abbou, CC .
UROLOGY, 2003, 61 (06) :1181-1186
[5]   Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: The center for prostate disease research nomograms [J].
Gancarczyk, KJ ;
Wu, HY ;
McLeod, DG ;
Kane, C ;
Kusuda, L ;
Lance, R ;
Herring, J ;
Foley, J ;
Baldwin, D ;
Bishoff, JT ;
Soderdahl, D ;
Moul, JW .
UROLOGY, 2003, 61 (03) :589-595
[6]   RANDOM SYSTEMATIC VERSUS DIRECTED ULTRASOUND GUIDED TRANS-RECTAL CORE BIOPSIES OF THE PROSTATE [J].
HODGE, KK ;
MCNEAL, JE ;
TERRIS, MK ;
STAMEY, TA .
JOURNAL OF UROLOGY, 1989, 142 (01) :71-75
[7]   The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy [J].
Lotan, Y ;
Shariat, SF ;
Khoddami, SM ;
Saboorian, H ;
Koeneman, KS ;
Cadeddu, JA ;
Sagalowsky, AI ;
McConnell, JD ;
Roehrborn, CG .
JOURNAL OF UROLOGY, 2004, 171 (06) :2209-2214
[8]   A comparison of extended biopsy and sextant biopsy schemes for predicting the pathological stage of prostate cancer [J].
Naya, Y ;
Ochiai, A ;
Troncoso, P ;
Babaian, RJ .
JOURNAL OF UROLOGY, 2004, 171 (06) :2203-2208
[9]   Radical prostatectomy for carcinoma of the prostate [J].
Ohori, M ;
Kattan, M ;
Scardino, PT ;
Wheeler, TM .
MODERN PATHOLOGY, 2004, 17 (03) :349-359
[10]   Predicting the presence and side of extracapsular extension: A nomogram for staging prostate cancer [J].
Ohori, M ;
Kattan, MW ;
Koh, H ;
Maru, N ;
Slawin, KM ;
Shariat, S ;
Muramoto, M ;
Reuter, VE ;
Wheeler, TM ;
Scardino, PT .
JOURNAL OF UROLOGY, 2004, 171 (05) :1844-1849